About Conference
The 38th International Conference on Immunology is scheduled for November 28-29, 2024, in Paris,France. This prestigious Immunology conference will gather leading immunologists, researchers, healthcare professionals, and industry experts from around the world to discuss the latest advancements and research in immunology.
This Immunology conference 2024 will feature a diverse program, including keynote speeches, plenary sessions, oral and poster presentations, and interactive workshops. Key topics will encompass a broad range of immunological research areas such as autoimmune diseases, infectious diseases, cancer immunotherapy, vaccine development, and immune system regulation. Renowned speakers will present cutting-edge research and innovative technological developments in these fields.
Who Should Attend
The 38th International Conference on Immunology is a prestigious event that attracts a diverse audience from the healthcare sector. Those who should attend include:
-
Immunologists
-
Virologists
-
Microbiologists
-
Biochemists
-
Oncologists
-
Allergists
-
Rheumatologists
-
Infectious disease specialists
-
Pharmacologists
-
Biomedical researchers
-
Clinical trial investigators
-
Pharmaceutical industry representatives
-
Biotechnology company executives
-
Public health policymakers
-
Immunotherapy developers
-
Vaccine researchers
-
Immunogenetics experts
-
Medical students
-
Postdoctoral fellows
Why to attend
Target Audience
Immunologist | Licensed behaviour analyst | Licensed professional counsellor | Immune health professional | School counsellor & Social Worker | Resource Worker | Graduates, Postgraduates & PhD Scholars | Professors, Associate Professors, Assistant Professors | Peer Support Worker | Grief and Bereavement Therapist | Manufacturing Companies | Research Institutes and members | Immunology Researchers | Immunosurgeons | Researchers
Benefits of Participation
Our extensive online advertising attracts 29000+ users and 49000+ views to our library of abstracts, driving researchers and speakers to our conference.
Meet hundreds of like-minded experts leading the Immunology Conference 2024 and share ideas.
All conference participants have a different reason to participate in one-on-one meetings with eminent speakers and famous keynote speakers.
In our keynote sessions you have a wonderful opportunity to hear what the world's experts are learning from the world's most influential researchers in the fields of Immunology.
Immunology 2024 Intensive Conference Schedule, you'll gain experience and expertise in crafting strategic gifts that are worth its weight golfing, creating an impressive array of recognized such professionals.
Outstanding Young Researcher Award.
Nomination for Best Poster Award.
Benefits of Participation for Speaker
Explore the latest analysis.
Worldwide appreciation of the research design.
Receive credit for professional development.
Learn a transition beyond your area of ​​interest to learn more about new topics and studies away from your core theme of the Immunology 2024.
We have exclusive networking, learning and integration in a single package.
Benefits of Participation for the Delegate
Attendance at conferences rejuvenates and energizes delegates.
Professional development - improving understanding and knowledge.
Your participation in our conference will help with a new approach and ideology that can be used to broaden the results of businesses or industries.
Opportunities for the Immunology 2024 for researchers and experts in the same field to meet and exchange new ideas through a physical conference.
Exposure to international environment will increase the chances of new companies.
Benefits of Participation for the Sponsor / Exhibitor
Opportunity to showcase your company's latest technologies, new products or serve your business to a wide range of international participants.
Building a successful company takes a lot of time and also lot of effort and drive, so it is always good to have a network of the colleagues and associates who draw energy from individuals who share a similar purpose and drive.
This Immunology and immunotherapy Conference in Immunology provide opportunities for greater focus and reflection that can help you take your company to the next step.
Benchmarking key organization plans.
For abstract submission
For registration
Participation Benefits
50% Registration & accommodation cost cover by conference sponsors.
Digital and Conference Publicity through Photo and affiliation details in Banner
80% discount on the publication of the full length article in our supporting journals.
Editorial published free in Special Issue of journal: 1 Editorial/Issue.
Awards will be given for the best paper presentation as well as best research paper.
Can launch a book or chapter in the conference or be a poster judge.
Join our team Immunology 2024 in this beautiful city Paris and let us make this professional gathering a Great success.
Market Analysis
Market analysis
Immunology conference 2024 welcomes attendees, presenters and exhibitors from all over the world to Paris, France. We are delighted to invite you all to attend and register for the “38th International Conference on Immunology” which is going to be held during November 28-29, 2024 at Paris, France.
The organizing committee is gearing up for an exciting and informative conference program which will include plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the 38th International Conference on Immunology, where you will be sure to have a meaningful experience with scholars from all around the world. All members of the organizing committee look forward to meeting you in Paris, France.
Importance & Scope:
The worldwide clinical immunology market is anticipated to achieve USD 5.77 Billion by 2022 from USD 3.35 Billion in 2017, developing at a CAGR of 11.5% from 2017 to 2022. Showcase development can be credited to variables, for example, the mechanical headways; rising rate of irresistible illnesses and developing flare-up of plagues; developing medicinal services consumption all over the world; and expanding financing, inquire about gifts, and open private interests in the field of Immunology.
The irresistible immunology market is sectioned in light of sorts of infections into tuberculosis, jungle fever, HIV, hepatitis, pneumonia, provocative inside sicknesses and immune system ailments. Around 4,00,000 passing's are evaluated to be brought about by rotavirus disease. HBV influenced almost 1.4 million in the U.S. in 2010. The rising frequency of these irresistible illnesses makes an overall interest for immunological diagnostics and its treatment. This recommends the market would encounter a development spurt sooner rather than later in the field of Immunology. Be that as it may, the absence of mechanical advancements and high cost related to the treatment would unfavourably influence advertise development. The irresistible immunology market is sectioned in the view of the sorts of items utilized for treatment, for example instruments, indicative units, and reagents. Demonstrative units hold the overwhelming offer because of their adequacy. Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories and Dr. Reddy's Laboratories are the key players in the immunology showcase.
MARKET GROWTH AND ANALYSIS IN THE HEALTHCARE INDUSTRY
Immunology plays a crucial role to maintain sustainable health of people across different countries; hence, they are employed in various regional disease-prevention strategies. The demand for vaccinations has increased over the past few years, owing to the increase in incidence of both bacterial and viral infectious diseases. Immunization are essentially administered to people of different age groups, which strengthen their immune system throughout lifetime and offers protection against different types of infectious diseases.
Global Vaccines Market was valued at $31,216 million in 2017, and is expected to reach $65,148 million in 2022, and register a CAGR of 10.9%, during the forecast period, 2017and 2022. Vaccine is a biological preparation that is administered to produce acquired immunity in the patient. Administration of vaccines aids to enhance the immune response against a specific pathogen.
The global immune market is driven by the rise in prevalence of infectious diseases, as it is considered to be the best way to prevent such diseases.However, longer timelines are required to produce vaccines and high monetary inputs associated with the same restrict the market growth. Furthermore, high growth of vaccine production in emerging markets are expected to offer lucrative opportunities in the near future.